Anti-CTLA-4 probody BMS-986249 alone or in combination with nivolumab in patients with advanced cancers: Initial phase I results Meeting Abstract
| Authors: | Gutierrez, M.; Long, G. V.; Friedman, C. F.; Richards, D. A.; Corr, B.; Bastos, B. R.; Uemura, M. I.; Conkling, P. R.; Moreno, V.; Edenfield, W. J.; Becerra, C. R.; Piha-Paul, S. A.; Peterson, A. C.; Brown, M.; James, L. P.; Zheng, M.; Jiang, J.; Kollia, G.; Swijter, A.; Ascierto, P. A. |
| Abstract Title: | Anti-CTLA-4 probody BMS-986249 alone or in combination with nivolumab in patients with advanced cancers: Initial phase I results |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 137s |
| Language: | English |
| ACCESSION: | WOS:000560368301318 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.3058 |
| Notes: | Meeting Abstract: 3058 -- Source: Wos |
